James Neuberger

Summary

Affiliation: Birmingham Heartlands Hospital
Country: UK

Publications

  1. ncbi Transplantation for alcoholic liver disease
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
    J Hepatol 36:130-7. 2002
  2. ncbi Impact factors: uses and abuses
    James Neuberger
    Research and Development Directorate, Queen Elizabeth Hospital, Birmingham, UK
    Eur J Gastroenterol Hepatol 14:209-11. 2002
  3. ncbi A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts
    Edward Alabraba
    Liver Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom
    Liver Transpl 15:330-40. 2009
  4. ncbi Detecting lifetime alcohol problems in individuals referred for liver transplantation for nonalcoholic liver failure
    Ed Day
    University of Birmingham Department of Psychiatry, Queen Elizabeth Psychiatric Hospital, Birmingham, UK
    Liver Transpl 14:1609-13. 2008
  5. ncbi Conditional organ donation: case scenarios and questions
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Transplantation 85:1527-9. 2008
  6. ncbi Transplantation in autoimmune liver diseases
    Marcus Mottershead
    Queen Elizabeth Hospital, Birmingham B15 2TH, UK
    World J Gastroenterol 14:3388-95. 2008
  7. ncbi Transplantation for alcoholic liver disease: report of a consensus meeting
    Kerry Webb
    Liver Unit, University Hospitals, Birmingham, United Kingdom
    Liver Transpl 12:301-5. 2006
  8. ncbi Predictors of psychological morbidity in liver transplant assessment candidates: is alcohol abuse or dependence a factor?
    Ed Day
    Department of Psychiatry, University of Birmingham, Birmingham, UK
    Transpl Int 22:606-14. 2009
  9. ncbi Recurrent nonviral liver disease following liver transplantation
    Ka Kit Li
    Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK
    Expert Rev Gastroenterol Hepatol 3:257-68. 2009
  10. ncbi Late protocol liver biopsies in the liver allograft: a neglected investigation?
    George Mells
    Liver Unit, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom
    Liver Transpl 15:931-8. 2009

Collaborators

Detail Information

Publications56

  1. ncbi Transplantation for alcoholic liver disease
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
    J Hepatol 36:130-7. 2002
  2. ncbi Impact factors: uses and abuses
    James Neuberger
    Research and Development Directorate, Queen Elizabeth Hospital, Birmingham, UK
    Eur J Gastroenterol Hepatol 14:209-11. 2002
    ..Like all measures, the use of Impact Factors has to be tempered with knowledge of their limitations and common sense used in interpreting any data based on any analysis...
  3. ncbi A re-evaluation of the risk factors for the recurrence of primary sclerosing cholangitis in liver allografts
    Edward Alabraba
    Liver Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom
    Liver Transpl 15:330-40. 2009
    ..Moreover, we have shown that EDC grafts are also a significant risk factor for rPSC...
  4. ncbi Detecting lifetime alcohol problems in individuals referred for liver transplantation for nonalcoholic liver failure
    Ed Day
    University of Birmingham Department of Psychiatry, Queen Elizabeth Psychiatric Hospital, Birmingham, UK
    Liver Transpl 14:1609-13. 2008
    ..These findings point to the need to take an adequate history of lifetime alcohol problems in all patients being considered for liver transplantation...
  5. ncbi Conditional organ donation: case scenarios and questions
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Transplantation 85:1527-9. 2008
  6. ncbi Transplantation in autoimmune liver diseases
    Marcus Mottershead
    Queen Elizabeth Hospital, Birmingham B15 2TH, UK
    World J Gastroenterol 14:3388-95. 2008
    ..For autoimmune diseases, transplantation is associated with significant improvement in the quality and length of life. Disease may recur after transplantation and may affect patient and graft survival...
  7. ncbi Transplantation for alcoholic liver disease: report of a consensus meeting
    Kerry Webb
    Liver Unit, University Hospitals, Birmingham, United Kingdom
    Liver Transpl 12:301-5. 2006
  8. ncbi Predictors of psychological morbidity in liver transplant assessment candidates: is alcohol abuse or dependence a factor?
    Ed Day
    Department of Psychiatry, University of Birmingham, Birmingham, UK
    Transpl Int 22:606-14. 2009
    ..Higher rates of psychological distress were associated with greater severity of liver disease, being unemployed, and being a tobacco smoker. Possible reasons for these findings and potential future management strategies are discussed...
  9. ncbi Recurrent nonviral liver disease following liver transplantation
    Ka Kit Li
    Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK
    Expert Rev Gastroenterol Hepatol 3:257-68. 2009
    ..Finally, an understanding of which diseases do recur after transplantation and identification of the risk factors may lead to a better understanding of the pathogenetic mechanisms of these conditions...
  10. ncbi Late protocol liver biopsies in the liver allograft: a neglected investigation?
    George Mells
    Liver Unit, Queen Elizabeth Hospital, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom
    Liver Transpl 15:931-8. 2009
    ..Liver Transpl 15:931-938, 2009. (c) 2009 AASLD...
  11. ncbi The impact of disease recurrence on graft survival following liver transplantation: a single centre experience
    Ian A Rowe
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Transpl Int 21:459-65. 2008
    ..Disease recurrence is a significant cause of graft loss particularly in HCV, PSC and AIH. Recurrent disease, in part, explains the increased overall risk of graft loss in these groups...
  12. ncbi Autoimmune hepatitis and liver transplantation: indications, results, and management of recurrent disease
    Dhiraj Tripathi
    Liver Unit, University Hospital Birmingham, NHS Foundation Trust, Birmingham B15 2TH, United Kingdom
    Semin Liver Dis 29:286-96. 2009
    ..There remains controversy over the role for protocol liver biopsies to detect recurrent disease and the best immunosuppressive strategies to prevent and treat recurrence...
  13. ncbi Public and professional attitudes to transplanting alcoholic patients
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Liver Transpl 13:S65-8. 2007
    ..Public education is required to demonstrate that patients with ALD are carefully selected for liver transplantation and available grafts are used with attention to equity, justice, and utility...
  14. ncbi Illicit drug use and liver transplantation: is there a problem and what is the solution?
    Kerry Webb
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Transpl Int 21:923-9. 2008
    ..UK guidelines on assessment and selection have been agreed. Careful assessment and access to treatment should be considered...
  15. ncbi Weight gain and obesity after liver transplantation
    James Richards
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Transpl Int 18:461-6. 2005
    ..The greatest weight gain occurs after the first 6 months and intervention with dietary advice at this point could be implemented to minimize the long-term morbidity and mortality risks associated with obesity...
  16. ncbi Liver transplantation for primary biliary cirrhosis
    Gerry C MacQuillan
    Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH England, UK
    Clin Liver Dis 7:941-56, ix. 2003
    ..Following transplantation, antimitochondrial antibodies persist and histological features of recurrent PBC may be seen in the allograft in up to 50% by 10 years; however, at least in the medium-term, this rarely causes clinical problems...
  17. ncbi Chronic allograft dysfunction: diagnosis and management. Is it always progressive?
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK
    Liver Transpl 11:S63-8. 2005
    ..5. Treatment is of the underlying cause but some, such as recurrent and de novo autoimmune hepatitis and recurrent primary sclerosing cholangitis may not respond well, and regraft may be required...
  18. ncbi Saline contrast echocardiography in patients with hepatopulmonary syndrome awaiting liver transplantation
    Ilaria Lenci
    Liver Unit, Queen Elizabeth University Hospital, Birmingham, UK
    J Am Soc Echocardiogr 22:89-94. 2009
    ....
  19. ncbi Conditional organ donation: the views of the UK general public findings of an Ipsos-Mori Poll
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Transplantation 85:1545-7. 2008
  20. ncbi Treatment of hepatitis C virus infection in the allograft
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham, England
    Liver Transpl 9:S101-8. 2003
    ..Side-effects of treatment are common and reduction/withdrawal is frequent, but the regime is cost-effective. 7. The role of newer treatments remains to be established...
  21. ncbi The management of patients awaiting liver transplantation
    Ka Kit Li
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Nat Rev Gastroenterol Hepatol 6:648-59. 2009
    ....
  22. ncbi Recurrence of nonviral diseases
    Ye Htun Oo
    Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Edgbaston, Birmingham, B15 2TH, United Kingdom
    Clin Liver Dis 11:377-95. 2007
    ..This article discusses the recurrence of nonviral diseases after liver transplantation, diagnosis, and management...
  23. ncbi Autoimmune liver diseases and recurrence after orthotopic liver transplantation: what have we learned so far?
    Tim C M A Schreuder
    Liver Unit, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK
    Transpl Int 22:144-52. 2009
    ..Risk factors for rPBC include use of tacrolimus compared with cyclosporine; for rPSC include absence of colon peri-transplantation and for rAIH possible associations with some HLA haplotypes have been suggested...
  24. ncbi Options for treatment of primary biliary cirrhosis
    Ye H Oo
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Drugs 64:2261-71. 2004
    ..For those who are intolerant of the drug or where it is ineffective, rifampicin and naltrexone may be effective. There is no effective treatment for the associated lethargy...
  25. ncbi Should liver transplantation be made available to everyone? The case against
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham, England
    Arch Intern Med 163:1881-3; discussion 1885-6. 2003
  26. ncbi Living liver donation: a survey of the attitudes of the public in Great Britain
    James Neuberger
    The Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom. J.M.Neuberger.ac.uk
    Transplantation 76:1260-4. 2003
    ..CONCLUSIONS: Most adults in Great Britain are in favor of LLD, although more than half believe that a donor risk of mortality of 1:200 is acceptable...
  27. ncbi Liver transplantation in PBC and PSC: indications and disease recurrence
    Marco Carbone
    Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK
    Clin Res Hepatol Gastroenterol 35:446-54. 2011
    ..The impact of recurrent disease on survival is unclear. Study of recurrent PBC and PSC may provide a better understanding of the mechanisms of these diseases in the native liver...
  28. ncbi Immunosuppression affects the rate of recurrent primary biliary cirrhosis after liver transplantation
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Liver Transpl 10:488-91. 2004
    ..For those receiving cyclosporine, the median time to recurrence was 123 months and for those on tacrolimus 62 months (P <.001). Reasons for this difference between the 2 calcineurin inhibitors are not clear...
  29. ncbi Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, 3rd Floor, Nuffield House, Edgbaston, Birmingham B15 2TH, UK
    J Hepatol 39:142-8. 2003
  30. ncbi Conditional organ donation forum introduction
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham, UK
    Transplantation 85:1526. 2008
  31. ncbi Daclizumab
    Marcus Mottershead
    Queen Elizabeth Hospital, Liver Unit, Birmingham, B15 2TH, UK
    Expert Opin Biol Ther 7:1583-96. 2007
    ..The agent is generally well tolerated in adults and children and there is no need for additional monitoring. Daclizumab has also been used outside the transplant arena in a variety of immune-mediated diseases with limited success...
  32. ncbi Selfless adults and split donor livers
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
    Lancet 370:299-300. 2007
  33. ncbi Reducing the risks of cardiovascular disease in liver allograft recipients
    George Mells
    Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom
    Transplantation 83:1141-50. 2007
    ..If monotherapy is inadequate, ezetimibe or a fibrate may be added. Consideration may be given to change in immunosuppression if combination lipid-lowering therapy proves inadequate...
  34. ncbi Role of living liver donation in the United Kingdom
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham B15 2TH
    BMJ 327:676-9. 2003
  35. ncbi Self-organizing maps can determine outcome and match recipients and donors at orthotopic liver transplantation
    Geoffrey H Haydon
    Liver Unit, Third Floor, Nuffield House, The Queen Elizabeth Hospital, Birmingham, UK
    Transplantation 79:213-8. 2005
    ..Ideally, to maximize the utility of those livers that are offered, donor and recipient characteristics should be matched to ensure the best possible posttransplant survival of the recipient...
  36. ncbi Alternative medicines and the liver
    Edward Fogden
    Liver Unit, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
    Liver Int 23:213-20. 2003
    ..Doctors need to be aware of the widespread use of CAM, ask their patients specifically regarding their use of CAM and be aware of the potential for hepatotoxicity and interactions...
  37. ncbi Acute liver failure: bridging to transplant or recovery--are we there yet?
    Amit Singhal
    The Liver Unit, Queen Elizabeth Hospital, Birmingham and University of Birmingham, UK
    J Hepatol 46:557-64. 2007
  38. ncbi Liver transplantation for primary biliary cirrhosis
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham B15 2TH, UK
    Autoimmun Rev 2:1-7. 2003
    ..Following transplantation, AMA persist and histological features of PBC may be seen in the allograft, in up to 50% by 10 years...
  39. ncbi Carriage of methicillin-resistant Staphylococcus aureus is associated with an increased risk of infection after liver transplantation
    Devendra Desai
    Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom
    Liver Transpl 9:754-9. 2003
    ..Screening for MRSA should be considered in high-risk patients being assessed for liver transplantation...
  40. ncbi Colorectal cancer in patients with inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis
    Alonso Vera
    Liver and Hepatobiliary Unit, Queen Elizabeth Hospital, Birmingham, England, United Kingdom
    Transplantation 75:1983-8. 2003
    ..We advocate long-term aggressive colonic surveillance and colectomy in selected high-risk patients with longstanding severe colitis...
  41. ncbi Recurrent primary biliary cirrhosis
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom
    Liver Transpl 9:539-46. 2003
    ..The diagnosis of recurrent PBC is made on the basis of a consistent history and demonstrating the histologic features of PBC on liver biopsy and exclusion of other causes of bile duct damage...
  42. ncbi Risk factors for recurrence of primary sclerosing cholangitis of liver allograft
    Alonso Vera
    Liver Unit, Queen Elizabeth Hospital, B15 2TH, Birmingham, UK
    Lancet 360:1943-4. 2002
    ..2, 95% CI 0.73-2.15) and an intact colon before transplantation (8.7, 1.19-64.48) were associated with recurrence. These observations could help elucidate the pathogenesis of the disease...
  43. ncbi Transplantation for autoimmune hepatitis
    James Neuberger
    Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom
    Semin Liver Dis 22:379-86. 2002
    ..Patients grafted for AIH tend to be at higher risk for both acute and chronic rejection. Withdrawal of immunosuppression is unlikely to be achieved...
  44. ncbi Cardiovascular morbidity and mortality after orthotopic liver transplantation
    Simon D Johnston
    Liver Unit, Queen Elizabeth Hospital, Birmingham, B15 2TH, UK
    Transplantation 73:901-6. 2002
    ....
  45. ncbi First report of a psychosocial intervention for patients with alcohol-related liver disease undergoing liver transplantation
    George Georgiou
    Addictive Behaviours Centre, Birmingham, England
    Liver Transpl 9:772-5. 2003
    ..The intervention was readily integrated into the usual transplantation process and was acceptable to both patients and staff. Further research is required to clarify its impact on longer-term outcome measures...
  46. ncbi Allocation of donor livers--is MELD enough?
    James Neuberger
    Liver Transpl 10:908-10. 2004
  47. ncbi Renal failure late after liver transplantation
    James Neuberger
    Liver Transpl 8:922-4. 2002
  48. ncbi Protocol liver allograft biopsies
    George Mells
    Transplantation 85:1686-92. 2008
    ....
  49. ncbi Midterm cost-effectiveness of the liver transplantation program of England and Wales for three disease groups
    Louise Longworth
    Health Economics Research Group, Brunel University, Uxbridge, Middlesex, UK
    Liver Transpl 9:1295-307. 2003
    ..Cost-effectiveness estimates were poorer for patients with ALD over the 27-month period than for patients with PBC or PSC. This in part reflects the costs of the higher number of ALD patients assessed for each transplant...
  50. ncbi Survival gain after liver transplantation for patients with alcoholic liver disease: a comparison across models and centers
    Tracey A Young
    Health Economics Research Group, Brunel University, Uxbridge, Middlesex UB8 3PH, UK
    Transplantation 76:1479-86. 2003
    ....
  51. ncbi Transplantation for alcoholic liver disease
    Kerry Webb
    BMJ 329:63-4. 2004
  52. ncbi Celiac disease-related autoantibodies in end-stage autoimmune liver diseases: what is the message?
    George N Dalekos
    Liver Int 28:426-8. 2008
  53. ncbi Nutritional markers in liver allograft recipients
    Mohammad Shahid
    St. Bartholomew's and the Royal London School of Medicine and Dentistry, Queen Mary College, University of London, London, UK
    Transplantation 79:359-62. 2005
    ..29, P=0.04) and TSFT (rho=+0.25, P=0.02). CONCLUSIONS: These findings suggest that nutritional parameters and markers of disease severity do not correlate well with outcomes after transplantation...
  54. ncbi HLA and outcome in living donor liver transplantation in primary biliary cirrhosis: a new piece in the jigsaw?
    Ye Htun Oo
    Liver Transpl 13:8-13. 2007
  55. ncbi Splitting livers - balancing the gain and the pain
    Dave Collett
    UK Transplant, Stoke Gifford, Bristol, UK
    Transpl Int 21:218-22. 2008
    ..While this analysis is based on a number of assumptions, and so the results must be treated with caution, it does give rise to a number of ethical considerations which require open and public debate...
  56. ncbi Grafts and hepatitis C virus: maximizing the benefit
    Marcus Mottershead
    Liver Transpl 13:947-52. 2007